Show simple item record

Management preferences following radical inguinal orchidectomy for Stage I testicular seminoma in Australasia

dc.contributor.authorHruby, G.en_US
dc.contributor.authorChoo, R.en_US
dc.contributor.authorJackson, M.en_US
dc.contributor.authorWarde, P.en_US
dc.contributor.authorSandler, Howard M.en_US
dc.date.accessioned2010-06-01T22:39:46Z
dc.date.available2010-06-01T22:39:46Z
dc.date.issued2002-09en_US
dc.identifier.citationHruby, G; Choo, R; Jackson, M; Warde, P; Sandler, H (2002). "Management preferences following radical inguinal orchidectomy for Stage I testicular seminoma in Australasia." Australasian Radiology 46(3): 280-284. <http://hdl.handle.net/2027.42/75636>en_US
dc.identifier.issn0004-8461en_US
dc.identifier.issn1440-1673en_US
dc.identifier.urihttps://hdl.handle.net/2027.42/75636
dc.identifier.urihttp://www.ncbi.nlm.nih.gov/sites/entrez?cmd=retrieve&db=pubmed&list_uids=12196237&dopt=citationen_US
dc.description.abstractA survey to evaluate the preferred patterns of management of Stage I seminoma was conducted during March 2001. The questionnaire was distributed by the Royal Australian and New Zealand College of Radiologists to all qualified radiation oncologists, 74 out of 170 responded. All performed a staging CT scan of the abdomen and pelvis. Thoracic imaging consisted of either chest X-ray (29%) or chest CT (38%) while 33% performed both. Fifty-four percent of radiation oncologists discussed surveillance with their patients but estimated that 5% or less would choose this option. The most commonly prescribed dose was 25 Gy in 15 or 20 fractions (79%). Sixty-five percent of respondents treated the para-aortic (PA) nodes alone. Forty-two of 48 clinicians treating the PA field reported a change in practice after publication of the Medical Research Council study in 1999. Of these, 40 and 23% perform CT scans of the pelvis annually and every 6 months. Thirty-one percent did no follow-up CT scan. Compared to a similar survey from North America, we are more likely to use PA fields and less likely to discuss surveillance. As in the USA, and in contrast to Canada, few patients choose surveillance. There is no consensus regarding the frequency of follow-up scans in either North America or Australasia.en_US
dc.format.extent79617 bytes
dc.format.extent3109 bytes
dc.format.mimetypeapplication/pdf
dc.format.mimetypetext/plain
dc.publisherBlackwell Science Ptyen_US
dc.rights2002 Royal Australian and New Zealand College of Radiologistsen_US
dc.subject.otherManagementen_US
dc.subject.otherRadiotherapy Surveillanceen_US
dc.subject.otherTesticular Seminomaen_US
dc.titleManagement preferences following radical inguinal orchidectomy for Stage I testicular seminoma in Australasiaen_US
dc.typeArticleen_US
dc.subject.hlbsecondlevelRadiologyen_US
dc.subject.hlbtoplevelHealth Sciencesen_US
dc.description.peerreviewedPeer Revieweden_US
dc.contributor.affiliationumDepartment of Radiation Oncology, University of Michigan Medical Centre, Ann-Arbor, Michigan, USAen_US
dc.contributor.affiliationotherDepartment of Radiation Oncology, Royal Prince Alfred Hospital, Sydney, New South Wales, Australia,en_US
dc.contributor.affiliationotherDepartment of Radiation Oncology, Toronto–Sunnybrook Regional Cancer Centre, Toronto, Ontario, Canadaen_US
dc.contributor.affiliationotherDepartment of Radiation Oncology, Princess Margaret Hospital, Toronto, Ontario, Canadaen_US
dc.identifier.pmid12196237en_US
dc.description.bitstreamurlhttp://deepblue.lib.umich.edu/bitstream/2027.42/75636/1/j.1440-1673.2002.01060.x.pdf
dc.identifier.doi10.1046/j.1440-1673.2002.01060.xen_US
dc.identifier.sourceAustralasian Radiologyen_US
dc.identifier.citedreferenceEpstein BE, Order SE, Zinreich ES. Staging, treatment and results in testicular seminoma: a 12 year report. Cancer 1990; 65: 405 – 11.en_US
dc.identifier.citedreferenceSchultz HP, von der Maase H, Rorth M. Testicular seminoma in Denmark 1976–80: Results of treatment. Acta Radiol Oncol 1984; 23: 263 – 70.en_US
dc.identifier.citedreferenceThomas GM, Rider WD, Dembo AJ. Seminoma of the Testis. Results of Treatment and Patterns of Failure after Radiation Therapy. Int J Radiat Oncol Biol Phys 1982; 8: 165 – 74.en_US
dc.identifier.citedreferenceWarde P, Specht L, von der Maase H et al. Prognostic factors for relapse in Stage I seminoma managed by surveillance (Abstract). J Urol 1999; 161: 158.en_US
dc.identifier.citedreferenceHorwich A, Alsanjari N, A’Hern R, Nicholls J, Dearneley DP, Fisher C. Surveillance following orchidectomy for Stage I testicular seminoma. Br J Cancer 1992; 65: 775 – 8.en_US
dc.identifier.citedreferencevon der Maase H, Specht L, Jacobsen GK et al. Surveillance following orchidectomy for Stage I seminoma of the testis. Eur J Cancer 1993; 14: 19 931 – 34.en_US
dc.identifier.citedreferenceWarde P, Gospodarowicz MK, Banerjee D et al. Prognostic factors for relapse in Stage I testicular seminoma treated with surveillance. J Urol 1997; 157: 1705 – 10.en_US
dc.identifier.citedreferenceFossa SD, Horwich A, Russell MJ et al. Optimal planning target Volume for Stage I testicular seminoma: a Medical Research Council randomized trial. J Clin Oncol 1999; 17: 1146 – 54.en_US
dc.identifier.citedreferenceDieckmann KP, Bruggeboes B, Pichlmeier U, Kuster J, Mullerleile U, Bartels H. Adjuvant treatment of clinical Stage I seminoma: Is a single course of carboplatin sufficient? Urology 2000; 55: 102 – 6.en_US
dc.identifier.citedreferenceReiter WJ, Brodwicz T, Alavi S et al. Twelve-year experience with two courses of adjuvant single-agent carboplatin therapy for clinical Stage I seminoma. J Clin Oncol 2002; 19: 101 – 4.en_US
dc.identifier.citedreferenceChoo R, Sandler H, Warde P, Hruby G, DeBoer G. Survey of radiation oncologists: Practice patterns of the management of stage 1 seminoma of the testis in Canada and a selected group in the United States. Can J Urol 2002; 9: 1479 – 85.en_US
dc.identifier.citedreferenceWarde P, Gospodarowicz MK, Panzarella T et al. Long term outcome and cost in the management of Stage I testicular seminoma. Can J Urol 2000; 7: 967 – 72.en_US
dc.identifier.citedreferenceSharda NN, Kinsella TJ, Ritter MA. Adjuvant radiation versus observation: a cost analysis of alternate management schemes in early-stage testicular seminoma. J Clin Oncol 1996; 14: 2933 – 9.en_US
dc.identifier.citedreferenceBajorin DF, Sarosdy MF, Pfister DG et al. Randomized trial of etoposide and cisplatin versus etoposide and carboplatin in patients with good-risk germ cell tumours: a multi-institutional study. J Clin Oncol 1993; 11: 598 – 606.en_US
dc.identifier.citedreferenceHorwich A, Sleijfer DT, Fossa SD et al. Randomized trial of bleomycin, etoposide and cisplatin compared with bleomycin, etoposide, and carboplatin in good prognosis metastatic nonseminomatous germ cell cancer: a multi-institutional Medical Research Council/ European Organization for Research and Treatment of Cancer trial. J Clin Oncol 1997; 15: 1844 – 52.en_US
dc.identifier.citedreferenceThomas GM. Is optimal radiation for Stage I seminoma yet defined? J Clin Oncol 1999; 17: 3004 – 5.en_US
dc.owningcollnameInterdisciplinary and Peer-Reviewed


Files in this item

Show simple item record

Remediation of Harmful Language

The University of Michigan Library aims to describe library materials in a way that respects the people and communities who create, use, and are represented in our collections. Report harmful or offensive language in catalog records, finding aids, or elsewhere in our collections anonymously through our metadata feedback form. More information at Remediation of Harmful Language.

Accessibility

If you are unable to use this file in its current format, please select the Contact Us link and we can modify it to make it more accessible to you.